IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP, LLC

Q4 2017 Holdings

Filed 2018-02-13 | 5 holdings | $70.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cytomx Therapeutics, Inc.(CTMX)COM23284F105$70.1M3,320,34899.8%
Rhythm Pharmaceuticals, Inc.(RYTM)COM76243J105$115.7K3,981,4370.2%
Kala Pharmaceuticals Inc.COM483119103$30.6K1,654,4250.0%
Eleven Biotherapeutics, Inc.COM286221106$3.9K4,841,5910.0%
Zafgen, Inc.COM98885E103$972210,3710.0%